Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.73 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.73 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 4/20 | 0.67 |
| ▸ | PPARD | Q03181 | 4/20 | 0.67 |
| ▸ | PPARA | Q07869 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | F7 | P08709 | 4/20 | 0.67 |
| ▸ | F3 | P13726 | 4/20 | 0.67 |
| ▸ | TERT | O14746 | 3/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | BLM | P54132 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | FABP4 | P15090 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.67 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15515107 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL19857556 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL9301707 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL23950035 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL9302927 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL23225824 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL23925417 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL23925418 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL22634134 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD | |
| SCHEMBL1950745 | 1.00 | FFAR1 (0.73) | FFAR1FFAR4GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023178193-A1 | ACYL-ACP THIOESTERASE VARIANTS AND USES THEREOF | GENOMATICA, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| US-11591535-B2 | Estolide esters and use thereof as a base oil in lubricants | Peter Greven GmbH & Co. KG (DE) | 2023-02-28 | — | — | US | claimed |
| WO-2023005520-A1 | BINDER, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州清陶新能源科技有限公司 | 2023-02-02 | — | — | WO | claimed |
| CN-113571709-B | Adhesive, preparation method and application thereof | 苏州清陶新能源科技有限公司 | 2022-07-19 | — | — | CN | claimed |
| US-20220112439-A1 | ESTOLIDE ESTERS AND USE THEREOF AS A BASE OIL IN LUBRICANTS | Peter Greven GmbH & Co. KG (DE) | 2022-04-14 | — | — | US | claimed |
| EP-3914677-A2 | ESTOLIDE ESTERS AND USE THEREOF AS A BASE OIL IN LUBRICANTS | Peter Greven GmbH & Co. KG (DE) | 2021-12-01 | — | — | EP | claimed |
| CN-113571709-A | Adhesive, preparation method and application thereof | 苏州清陶新能源科技有限公司 | 2021-10-29 | — | — | CN | claimed |
| US-11013711-B2 | Fatty acid esters of hydroxy fatty acids (FAHFAs) for use in the treatment of type 1 diabetes | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2021-05-25 | — | — | US | claimed |
| US-20190151276-A1 | Fatty Acid Esters Of Hydroxy Fatty Acids (FAHFAs) For Use In The Treatment Of Type 1 Diabetes | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2019-05-23 | — | — | US | claimed |
| WO-2017214527-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACIDS (FAHFAS) FOR USE IN THE TREATMENT OF TYPE 1 DIABETES | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2017-12-14 | — | — | WO | claimed |
| US-20110136988-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific an dIndustrial Research Organisation (AU) | 2011-06-09 | — | — | US | claimed |
| US-20110126325-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION | 2011-05-26 | — | — | US | claimed |
| EP-2283137-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-02-16 | — | — | EP | claimed |
| EP-2265661-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | Commonwealth Scientific and Industrial Research Organisation (AU) | 2010-12-29 | — | — | EP | claimed |
| WO-2010102862-A1 | PHARMACEUTICAL FORMULATION COMPRISING KETOPROFEN AND A POLYOXYALKYLENE ESTER OF A HYDROXY FATTY ACID | ADVANCE HOLDINGS LIMITED (MT) | 2010-09-16 | — | — | WO | claimed |
| WO-2010060798-A1 | PHARMACEUTICAL FORMULATION COMPRISING DICLOFENAC AND A HYDROXY FATTY ACID POLYOXYALKYLENE ESTER | ADVANCE HOLDINGS LIMITED (MT) | 2010-06-03 | — | — | WO | claimed |
| WO-2009129583-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-29 | — | — | WO | claimed |
| WO-2009127010-A1 | CONDENSATION POLYMERS WITH MODIFIED PROPERTIES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-22 | — | — | WO | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-0937719-B1 | Process for the preparation of CIS-isoambrettoldide and her application | SYNAROME (FR) | 2002-04-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151276-A1 | Fatty Acid Esters Of Hydroxy Fatty Acids (FAHFAs) For Use In The Treatment Of Type 1 Diabetes | ELOVL1, FADS1, ELOVL3 | FFAR1 6/4885FFAR4 17/4885GPR84 420/4885 |
| US-11013711-B2 | Fatty acid esters of hydroxy fatty acids (FAHFAs) for use in the treatment of type 1 diabetes | ELOVL1, FADS1, ELOVL3 | FFAR1 6/4885FFAR4 17/4885GPR84 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.